This inventor holds 3 USPTO granted patents. Top assignee: Oxon Medica Inc.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxford, GB (2002)
- Marsh Baldon, GB (2004)
Company Filing History:
Years Active: 2002-2004
Title: Innovations of Erik Emil Anggard
Introduction
Erik Emil Anggard is a notable inventor based in Oxford, GB. He has made significant contributions to the field of chemistry, particularly in the development of compounds that address oxidative stress and endothelial dysfunction. With a total of 3 patents to his name, Anggard's work is paving the way for advancements in medical treatments.
Latest Patents
One of Anggard's latest patents focuses on piperidine and pyrrolidine derivatives that comprise a nitric oxide donor for treating stress. This invention relates to chemical compounds that include a nitric oxide (NO) donor and a superoxide ion (O ) scavenger. The compounds are designed for the treatment of conditions associated with oxidative stress or endothelial dysfunction. Specifically, the invention details chemical compounds of Formula (I), where R groups can be independently selected from a variety of functional groups, ensuring at least one R group includes an NO-donor.
Career Highlights
Anggard is currently associated with Oxon Medica Inc., where he continues to innovate and develop new chemical compounds. His work is characterized by a strong focus on improving health outcomes through scientific research and development.
Collaborations
Anggard collaborates with Abdullah Ibrahim Haj-Yehia, contributing to the advancement of their shared research goals.
Conclusion
Erik Emil Anggard's contributions to the field of chemistry and his innovative patents highlight his commitment to addressing critical health issues. His work continues to inspire advancements in medical treatments and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile